CN105861658A - 一种筛选优良发育囊胚的无创检测方法 - Google Patents
一种筛选优良发育囊胚的无创检测方法 Download PDFInfo
- Publication number
- CN105861658A CN105861658A CN201610225668.5A CN201610225668A CN105861658A CN 105861658 A CN105861658 A CN 105861658A CN 201610225668 A CN201610225668 A CN 201610225668A CN 105861658 A CN105861658 A CN 105861658A
- Authority
- CN
- China
- Prior art keywords
- blastaea
- embryo
- level
- methylation
- chromosome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 33
- 238000012216 screening Methods 0.000 title claims abstract description 28
- 210000000625 blastula Anatomy 0.000 title abstract 6
- 230000011987 methylation Effects 0.000 claims abstract description 97
- 238000007069 methylation reaction Methods 0.000 claims abstract description 97
- 238000000034 method Methods 0.000 claims abstract description 51
- 210000000349 chromosome Anatomy 0.000 claims abstract description 50
- 210000000251 trophoblastic cell Anatomy 0.000 claims abstract description 24
- 238000012360 testing method Methods 0.000 claims abstract description 21
- 230000035935 pregnancy Effects 0.000 claims abstract description 14
- 230000007067 DNA methylation Effects 0.000 claims abstract description 12
- 210000001161 mammalian embryo Anatomy 0.000 claims description 157
- 210000004027 cell Anatomy 0.000 claims description 41
- 238000012163 sequencing technique Methods 0.000 claims description 12
- 230000001035 methylating effect Effects 0.000 claims description 4
- 230000013020 embryo development Effects 0.000 claims description 3
- 238000007689 inspection Methods 0.000 claims description 3
- 238000003556 assay Methods 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 210000002257 embryonic structure Anatomy 0.000 abstract description 26
- 238000005516 engineering process Methods 0.000 abstract description 20
- 230000000877 morphologic effect Effects 0.000 abstract description 11
- 210000002459 blastocyst Anatomy 0.000 abstract description 10
- 230000002159 abnormal effect Effects 0.000 abstract description 8
- 206010000210 abortion Diseases 0.000 abstract description 4
- 231100000176 abortion Toxicity 0.000 abstract description 4
- 230000002068 genetic effect Effects 0.000 abstract description 3
- 230000008569 process Effects 0.000 abstract description 3
- 238000002054 transplantation Methods 0.000 abstract description 2
- 238000013459 approach Methods 0.000 abstract 1
- 230000008774 maternal effect Effects 0.000 abstract 1
- 238000012164 methylation sequencing Methods 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 description 24
- 239000000523 sample Substances 0.000 description 22
- 108020004414 DNA Proteins 0.000 description 18
- 239000012634 fragment Substances 0.000 description 13
- 239000011324 bead Substances 0.000 description 10
- 230000008175 fetal development Effects 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 9
- 239000003153 chemical reaction reagent Substances 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 230000001973 epigenetic effect Effects 0.000 description 8
- 239000003623 enhancer Substances 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 7
- 208000031404 Chromosome Aberrations Diseases 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 238000011161 development Methods 0.000 description 6
- 230000018109 developmental process Effects 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 206010000234 Abortion spontaneous Diseases 0.000 description 5
- 108091028043 Nucleic acid sequence Proteins 0.000 description 5
- 238000003745 diagnosis Methods 0.000 description 5
- 239000007943 implant Substances 0.000 description 5
- 238000003752 polymerase chain reaction Methods 0.000 description 5
- 230000011218 segmentation Effects 0.000 description 5
- 208000000995 spontaneous abortion Diseases 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 238000012408 PCR amplification Methods 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 210000003754 fetus Anatomy 0.000 description 4
- 238000002509 fluorescent in situ hybridization Methods 0.000 description 4
- 238000002513 implantation Methods 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000000513 principal component analysis Methods 0.000 description 4
- 230000008672 reprogramming Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 210000004340 zona pellucida Anatomy 0.000 description 4
- 108091029430 CpG site Proteins 0.000 description 3
- 101150104906 Idh2 gene Proteins 0.000 description 3
- 208000034702 Multiple pregnancies Diseases 0.000 description 3
- 208000006399 Premature Obstetric Labor Diseases 0.000 description 3
- 206010036600 Premature labour Diseases 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 210000001726 chromosome structure Anatomy 0.000 description 3
- 230000001186 cumulative effect Effects 0.000 description 3
- 230000004069 differentiation Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000006607 hypermethylation Effects 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 210000000982 limb bud Anatomy 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 208000015994 miscarriage Diseases 0.000 description 3
- 210000002826 placenta Anatomy 0.000 description 3
- 230000002980 postoperative effect Effects 0.000 description 3
- 208000026440 premature labor Diseases 0.000 description 3
- 239000002356 single layer Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 206010064571 Gene mutation Diseases 0.000 description 2
- 208000008899 Habitual abortion Diseases 0.000 description 2
- 101000782147 Homo sapiens WD repeat-containing protein 20 Proteins 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 230000003322 aneuploid effect Effects 0.000 description 2
- 208000036878 aneuploidy Diseases 0.000 description 2
- 239000012148 binding buffer Substances 0.000 description 2
- 230000022131 cell cycle Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 229940104302 cytosine Drugs 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 230000004720 fertilization Effects 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 238000013412 genome amplification Methods 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 238000012165 high-throughput sequencing Methods 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000000472 morula Anatomy 0.000 description 2
- 230000007472 neurodevelopment Effects 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 210000004681 ovum Anatomy 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000005945 translocation Effects 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 239000011534 wash buffer Substances 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- 108091062157 Cis-regulatory element Proteins 0.000 description 1
- 230000035131 DNA demethylation Effects 0.000 description 1
- 230000008836 DNA modification Effects 0.000 description 1
- 230000033616 DNA repair Effects 0.000 description 1
- 208000031448 Genomic Instability Diseases 0.000 description 1
- 101000931098 Homo sapiens DNA (cytosine-5)-methyltransferase 1 Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000024556 Mendelian disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 208000018525 Postpartum Hemorrhage Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001109 blastomere Anatomy 0.000 description 1
- 239000008004 cell lysis buffer Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 238000003200 chromosome mapping Methods 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000017858 demethylation Effects 0.000 description 1
- 238000010520 demethylation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000002219 extraembryonic membrane Anatomy 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 239000012520 frozen sample Substances 0.000 description 1
- 238000010230 functional analysis Methods 0.000 description 1
- 238000012224 gene deletion Methods 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 238000010448 genetic screening Methods 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 230000016507 interphase Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000013139 quantization Methods 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000003765 sex chromosome Anatomy 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 238000012070 whole genome sequencing analysis Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
- C12Q2525/10—Modifications characterised by
- C12Q2525/173—Modifications characterised by incorporating a polynucleotide run, e.g. polyAs, polyTs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
- C12Q2525/10—Modifications characterised by
- C12Q2525/191—Modifications characterised by incorporating an adaptor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2531/00—Reactions of nucleic acids characterised by
- C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
- C12Q2531/113—PCR
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
- C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
- C12Q2537/164—Methylation detection other then bisulfite or methylation sensitive restriction endonucleases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
样品名称 | 性染色体XX/XY | 染色体异常 |
1_4AA_350 | XY | |
11_3CC_sort | XY | |
13_6AA_sort | XY | |
2-4CC_sort | XX | |
7_3CC_sort | XX | |
8-3CC-350 | XY | |
9-3CC-350 | X | \+7 |
BL-1-2CB | XY | |
BL-1-4AA | XX | |
BL-2-2CC | XY | -21 |
BL-2-4AA | XY | -19 |
MLCC-19 | XX | \+8,-18 |
MLCC-20 | XX | |
MLCC-21 | XY | \+4 |
s_11-4BA | XX | -22 |
s_12-4CB | XY | |
s_13-5CB | XY | \-15,+17 |
s_15-4CA | XY | -20 |
s_16-4BA | XX | \+22,+2 |
s_17-4CC | XY | \+2,+8,-16,-18,+21 |
s_25-4CC | XY | \+5Q,-9Q |
s_31-5BC | XY | \-21,-22 |
s_32-5CC | XX | \+22 |
s_43-4BB | XY | |
s_44-4CC | XY | |
s_54-4BC | XX | -14 |
s_6-4BB | XX | \+1P |
s_6-5AA | XY | \-1P,-4P |
s1 | XX | |
s4AA-13 | XY | |
s4AA-14 | XY | |
s4CC-22 | XY | |
s4CC-23 | XX | |
s4CC-24 | XY | |
s4CC-25 | XX | |
s4CC-26 | X | -X |
Claims (10)
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610225668.5A CN105861658B (zh) | 2016-04-12 | 2016-04-12 | 一种筛选优良发育囊胚的无创检测方法 |
PT177818762T PT3444357T (pt) | 2016-04-12 | 2017-04-11 | Método de deteção não invasivo para o rastreio de blástulas de crescimento saudável |
EA201892308A EA201892308A1 (ru) | 2016-04-12 | 2017-04-11 | Способ неинвазивного выявления, предназначенный для скрининга в отношении хорошо развитой бластоцисты |
JP2019503616A JP6932765B2 (ja) | 2016-04-12 | 2017-04-11 | 発育良好な胚盤胞をスクリーニングする非侵襲的な検出方法 |
KR1020187032703A KR102222038B1 (ko) | 2016-04-12 | 2017-04-11 | 발육이 우수한 포배를 선별하는 비침습적 검사 방법 |
HUE17781876A HUE054193T2 (hu) | 2016-04-12 | 2017-04-11 | Noninvazív detektálási módszer az egészségesen növekvõ blasztulák szûrésére |
ES17781876T ES2858849T3 (es) | 2016-04-12 | 2017-04-11 | Método de detección no invasivo para el cribado de blástulas de crecimiento saludable |
PCT/CN2017/080102 WO2017177900A1 (zh) | 2016-04-12 | 2017-04-11 | 一种筛选优良发育囊胚的无创检测方法 |
EP17781876.2A EP3444357B1 (en) | 2016-04-12 | 2017-04-11 | Noninvasive detection method for screening healthily-growing blastulas |
PL17781876T PL3444357T3 (pl) | 2016-04-12 | 2017-04-11 | Nieinwazyjny sposób wykrywania do badań przesiewowych zdrowo rozwijających się blastuli |
US16/093,545 US20190161811A1 (en) | 2016-04-12 | 2017-04-11 | A non-invasive detection method for screening for a well-developed blastocyst |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610225668.5A CN105861658B (zh) | 2016-04-12 | 2016-04-12 | 一种筛选优良发育囊胚的无创检测方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105861658A true CN105861658A (zh) | 2016-08-17 |
CN105861658B CN105861658B (zh) | 2020-07-28 |
Family
ID=56636342
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610225668.5A Active CN105861658B (zh) | 2016-04-12 | 2016-04-12 | 一种筛选优良发育囊胚的无创检测方法 |
Country Status (11)
Country | Link |
---|---|
US (1) | US20190161811A1 (zh) |
EP (1) | EP3444357B1 (zh) |
JP (1) | JP6932765B2 (zh) |
KR (1) | KR102222038B1 (zh) |
CN (1) | CN105861658B (zh) |
EA (1) | EA201892308A1 (zh) |
ES (1) | ES2858849T3 (zh) |
HU (1) | HUE054193T2 (zh) |
PL (1) | PL3444357T3 (zh) |
PT (1) | PT3444357T (zh) |
WO (1) | WO2017177900A1 (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107419029A (zh) * | 2017-09-18 | 2017-12-01 | 北京积水潭医院 | 一种筛选优质囊胚的试剂盒 |
CN109943628A (zh) * | 2018-12-11 | 2019-06-28 | 北京中科遗传与生殖医学研究院有限责任公司 | 利用DedscRRBS分析法对活检细胞进行PGS及甲基化分析的方法 |
CN112582022A (zh) * | 2020-07-21 | 2021-03-30 | 序康医疗科技(苏州)有限公司 | 用于无创胚胎移植优先级评级的系统和方法 |
CN112574944A (zh) * | 2020-12-14 | 2021-03-30 | 广州医科大学附属第三医院(广州重症孕产妇救治中心、广州柔济医院) | 基于体外诱导eps发育形成类囊胚结构的方法 |
CN114480629A (zh) * | 2022-04-15 | 2022-05-13 | 北京大学第三医院(北京大学第三临床医学院) | 一种同时实现囊胚非整倍体检测和高着床潜能筛选的方法 |
CN115612723A (zh) * | 2022-09-26 | 2023-01-17 | 广州女娲生命科技有限公司 | 植入前胚胎的筛选方法 |
CN115910211A (zh) * | 2022-12-15 | 2023-04-04 | 广州女娲生命科技有限公司 | 胚胎植入前dna分析检测方法及装置 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX342210B (es) * | 2010-07-13 | 2016-09-20 | Univfy Inc * | Metodo para evaluar el riesgo de nacimientos multiples en tratamientos de infertilidad. |
-
2016
- 2016-04-12 CN CN201610225668.5A patent/CN105861658B/zh active Active
-
2017
- 2017-04-11 ES ES17781876T patent/ES2858849T3/es active Active
- 2017-04-11 EA EA201892308A patent/EA201892308A1/ru unknown
- 2017-04-11 HU HUE17781876A patent/HUE054193T2/hu unknown
- 2017-04-11 WO PCT/CN2017/080102 patent/WO2017177900A1/zh active Application Filing
- 2017-04-11 EP EP17781876.2A patent/EP3444357B1/en active Active
- 2017-04-11 PT PT177818762T patent/PT3444357T/pt unknown
- 2017-04-11 JP JP2019503616A patent/JP6932765B2/ja active Active
- 2017-04-11 PL PL17781876T patent/PL3444357T3/pl unknown
- 2017-04-11 US US16/093,545 patent/US20190161811A1/en active Pending
- 2017-04-11 KR KR1020187032703A patent/KR102222038B1/ko active IP Right Grant
Non-Patent Citations (3)
Title |
---|
DANIEL M. MESSERSCHMIDT ET AL.: "DNA methylation dynamics during epigenetic reprogramming in the germline and preimplantation embryos", 《GENES & DEVELOPMENT》 * |
FÁTIMA SANTOS ET AL.: "Evaluation of epigenetic marks in human embryos derived from IVF and ICSI", 《HUMAN REPRODUCTION》 * |
JUN-YU MA ET AL.: "Active DNA demethylation in mammalian preimplantation embryos: new insights and new perspectives", 《MOLECULAR HUMAN REPRODUCTION》 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107419029A (zh) * | 2017-09-18 | 2017-12-01 | 北京积水潭医院 | 一种筛选优质囊胚的试剂盒 |
CN109943628A (zh) * | 2018-12-11 | 2019-06-28 | 北京中科遗传与生殖医学研究院有限责任公司 | 利用DedscRRBS分析法对活检细胞进行PGS及甲基化分析的方法 |
CN112582022A (zh) * | 2020-07-21 | 2021-03-30 | 序康医疗科技(苏州)有限公司 | 用于无创胚胎移植优先级评级的系统和方法 |
CN112574944A (zh) * | 2020-12-14 | 2021-03-30 | 广州医科大学附属第三医院(广州重症孕产妇救治中心、广州柔济医院) | 基于体外诱导eps发育形成类囊胚结构的方法 |
CN114480629A (zh) * | 2022-04-15 | 2022-05-13 | 北京大学第三医院(北京大学第三临床医学院) | 一种同时实现囊胚非整倍体检测和高着床潜能筛选的方法 |
CN115612723A (zh) * | 2022-09-26 | 2023-01-17 | 广州女娲生命科技有限公司 | 植入前胚胎的筛选方法 |
WO2024065983A1 (zh) * | 2022-09-26 | 2024-04-04 | 广州女娲生命科技有限公司 | 植入前胚胎的筛选方法 |
CN115910211A (zh) * | 2022-12-15 | 2023-04-04 | 广州女娲生命科技有限公司 | 胚胎植入前dna分析检测方法及装置 |
CN115910211B (zh) * | 2022-12-15 | 2024-03-22 | 广州女娲生命科技有限公司 | 胚胎植入前dna分析检测方法及装置 |
Also Published As
Publication number | Publication date |
---|---|
US20190161811A1 (en) | 2019-05-30 |
ES2858849T3 (es) | 2021-09-30 |
EA201892308A1 (ru) | 2019-03-29 |
EP3444357A4 (en) | 2019-09-25 |
KR20180134387A (ko) | 2018-12-18 |
JP6932765B2 (ja) | 2021-09-08 |
PT3444357T (pt) | 2021-02-25 |
JP2019513417A (ja) | 2019-05-30 |
WO2017177900A1 (zh) | 2017-10-19 |
HUE054193T2 (hu) | 2021-08-30 |
KR102222038B1 (ko) | 2021-03-03 |
EP3444357B1 (en) | 2020-12-16 |
EP3444357A1 (en) | 2019-02-20 |
CN105861658B (zh) | 2020-07-28 |
PL3444357T3 (pl) | 2021-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105861658A (zh) | 一种筛选优良发育囊胚的无创检测方法 | |
CN104726494B (zh) | CRISPR-Cas9技术构建染色体易位干细胞及动物模型的方法 | |
CN106544407B (zh) | 确定受体cfDNA样本中供体来源cfDNA比例的方法 | |
CN104745718B (zh) | 一种检测人类胚胎染色体微缺失和微重复的方法 | |
CN105400810A (zh) | 采用敲除技术建立低磷性佝偻病模型的方法 | |
CN109797197A (zh) | 一种单链分子标签接头及单链dna建库方法及其在检测循环肿瘤dna中应用 | |
CN103627673B (zh) | 一种人脑胶质瘤细胞系及其建立方法和应用 | |
CN109112209B (zh) | 用于无创产前检测胎儿非整倍体染色体的参考品 | |
CN103667349B (zh) | 一种高效获取猪诱导性多能干细胞的方法 | |
JP2019513417A5 (zh) | ||
CN105838791A (zh) | 一种挖掘鸡胚胎干细胞向雄性生殖细胞分化过程中关键lncRNA 的分析方法 | |
CN106650310A (zh) | 一种鉴别染色体平衡易位携带胚胎和正常胚胎的方法 | |
CN108265110A (zh) | 一种人brca1/brca2基因突变检测试剂盒 | |
CN108504625A (zh) | 一种小鼠成纤维细胞及其用途 | |
CN105950656A (zh) | 一种快速获得基因敲除细胞株的方法 | |
CN105543372B (zh) | 一种检测染色体罗氏易位的方法 | |
CN105420233A (zh) | Hbb基因突变和hla分型检测试剂盒 | |
CN109920479A (zh) | 一种鉴别胚胎染色体倒位携带状态的方法 | |
CN115216545A (zh) | 用于无创植入前非整倍体遗传检测的方法 | |
CN111154851A (zh) | 基于高通量测序的胚胎植入前染色体非整倍体检测参考品及其制备方法 | |
WO2022242285A1 (zh) | 一种从孕妇宫颈脱落细胞中分离胎盘滋养层细胞的方法 | |
CN113684282B (zh) | 一种基于edar基因表达量检测猪无毛性状的方法及其应用 | |
CN115938481A (zh) | 一种基于靶向捕获和序列随机测序的通用型胚胎遗传变异检测技术方法和系统 | |
Yizhar-Barnea et al. | Single cell analysis of the inner ear sensory organs | |
CN106635980A (zh) | 一种自发永生化的绵羊外周血来源细胞系及其建立方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: No. 1-104, Beichen West Road, Chaoyang District, Beijing 100102 Patentee after: Beijing Institute of genomics, Chinese Academy of Sciences Patentee after: PEKING UNIVERSITY THIRD Hospital Patentee after: THE THIRD AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL University Address before: 100101 building 104, courtyard 1, Beichen West Road, Chaoyang District, Beijing Patentee before: BEIJING INSTITUTE OF GENOMICS, CHINESE ACADEMY OF SCIENCES Patentee before: PEKING UNIVERSITY THIRD Hospital Patentee before: THE THIRD AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL University |
|
CP03 | Change of name, title or address | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210901 Address after: 510570 596, room 406, No. 1, Yichuang street, Huangpu District, Guangzhou City, Guangdong Province (Zhongxin Guangzhou Knowledge City) Patentee after: Guangzhou Nuwa Life Technology Co.,Ltd. Address before: 100102 Chaoyang District, Beijing, China 1-104 Beichen West Road, Chaoyang District, Beijing Patentee before: Beijing Institute of genomics, Chinese Academy of Sciences Patentee before: PEKING UNIVERSITY THIRD Hospital Patentee before: THE THIRD AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL University |
|
TR01 | Transfer of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A noninvasive detection method for screening excellent developing blastocysts Effective date of registration: 20220516 Granted publication date: 20200728 Pledgee: Bank of China Limited Guangzhou Development Zone Branch Pledgor: Guangzhou Nuwa Life Technology Co.,Ltd. Registration number: Y2022980005663 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230515 Granted publication date: 20200728 Pledgee: Bank of China Limited Guangzhou Development Zone Branch Pledgor: Guangzhou Nuwa Life Technology Co.,Ltd. Registration number: Y2022980005663 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A non-invasive detection method for screening well-developed blastocysts Effective date of registration: 20230518 Granted publication date: 20200728 Pledgee: Bank of China Limited Guangzhou Development Zone Branch Pledgor: Guangzhou Nuwa Life Technology Co.,Ltd. Registration number: Y2023980040943 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |